Abstract:Abstract The nerve injury-induced protein 1 (Ninjurin1, Ninj1), a homophilic adhesion molecule, is involved in nerve regeneration, inflammation and vascular regression. Ninj1 is found to be overexpressed in human cancers including hepatocellular carcinoma and acute lymphoblastic leukemia. However, the role of Ninj1 in tumorigenesis has not been elucidated. Recently, we found that Ninj1 is transcriptionally regulated by p53, which in turn regulates p53 expression through mRNA translation. Thus, the mutual regulation between p53 and Ninj1 represents a novel loop in the p53 pathway. To examine the biological significance of the p53-Ninj1 loop, we generated and monitored 4 cohorts of mice: (i) WT, (ii) Ninj1-het, (iii) p53-null, (iv) Ninj1-het; p53-null. We found that Ninj1-het mice were highly prone to skin lesions. We also found that Ninj1 deficiency shortened the life-span but decreased the incidence of sarcoma in mice without p53. Additionally, we found that Ninj1-het; p53-null mice were prone to hydrocephalus and kidney abnormality. To examine the association of Ninj1 with mutant p53, we generated and characterized Ninj1+/-; p53 R270H/- and p53 R270H/- mice. We found that Ninj1 deficiency shortened the life-span and promoted the frequency and aggressiveness of tumors in p53 R270H/- mice. Together, we conclude that Ninj1 differently regulates the tumor susceptibility in a p53-dependent manner in vivo and that the Ninj1-p53 loop plays a pivotal role in tumor suppression and longevity. Citation Format: Hee Jung Yang, Seong Jun Cho, Jin Zhang, Wensheng Yan, Xinbin Chen. Ninjurin1, a target of p53, modulates p53-dependent tumor suppression in vivo. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 675.

Jagged 1 Promotes Tumorigenesis

Abstract 675: Ninjurin1, a Target of P53, Modulates P53-Dependent Tumor Suppression in Vivo

Jagged1 is Clinically Prognostic and Promotes Invasion of Glioma-Initiating Cells by Activating NF-κB(p65) Signaling

Tumor-derived Jagged1 promotes cancer progression through immune evasion

Jagged1-Notch1-deployed Tumor Perivascular Niche Promotes Breast Cancer Stem Cell Phenotype Through Zeb1.

Supplementary Figure 5 from the NOTCH Ligand JAGGED2 Promotes Pancreatic Cancer Metastasis Independent of NOTCH Signaling Activation

Advances of NOTCH 1 Signaling in Cervical Cancer

The NOTCH Ligand JAGGED2 Promotes Pancreatic Cancer Metastasis Independent of NOTCH Signaling Activation

Recent Researches on the Notch Signaling Pathway

Study of the Role of Jagged 1 in Physiological and Pathological Neovascularization

Role of Jagged1/STAT3 signalling in platinum-resistant ovarian cancer.

Androgen Receptor Promotes the Oncogenic Function of Overexpressed Jagged1 in Prostate Cancer by Enhancing Cyclin B1 Expression Via Akt Phosphorylation

Expression of Jagged 1 Predicts Postoperative Clinical Outcome of Patients with Gastric Cancer

High Jagged1 Expression Predicts Poor Outcome in Clear Cell Renal Cell Carcinoma

Crosstalk Between Tumor and Endothelial Cells Promotes Tumor Angiogenesis by MAPK Activation of Notch Signaling

Yes-associated Protein 1 Promotes the Metastasis of U251 Glioma Cells by Upregulating Jagged-1 Expression and Activating the Notch Signal Pathway.

Roles of Jagged1 in the Immuno-tolerance Induced by Dendritic Cells

Suppression of tongue squamous cell carcinoma growth by inhibition of Jagged1 in vitro and in vivo.

Expression of Jagged-1 in Cervical Carcinoma

Antagonism Between Hedgehog and Wnt Signaling Pathways Regulates Tumorigenicity

TGFβ1‐Smad3‐Jagged1‐Notch1–Slug Signaling Pathway Takes Part in Tumorigenesis and Progress of Tongue Squamous Cell Carcinoma